PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Call for papers: JMIR Bioinformatics and Biotechnology

JMIR Bioinformatics and Biotechnology, published by JMIR Publications, welcomes submissions on all aspects of bioinformatics, computational biology, and biotechnology

Call for papers: JMIR Bioinformatics and Biotechnology
2023-06-12
(Press-News.org) JMIR Bioinformatics and Biotechnology (JBB) is a leading, international, peer-reviewed journal that aims to publish high-quality original research articles, reviews, and perspectives on all aspects of bioinformatics, computational biology, and biotechnology. 

We invite researchers, educators, and practitioners to submit their original research articles, reviews, and perspectives to JBB. Our scope includes but is not limited to:

Bioinformatics, including genomic variation detection algorithms, tools, and databases Artificial intelligence (AI) applications in genomics and pathology informatics, including “Generative AI” Mathematical modeling in biological systems, including drug delivery and discovery Genomic data visualization Network biology Structural biology and molecular modeling Drug discovery and development Microbial genomics and metagenomics Cancer genomic data analysis JBB will support the development of new bioinformatics analysis tools, novel algorithms, advanced AI-based predictive models, and network biology studies. We would like to foster not only basic science and algorithm development but also translational research studies in the focus areas listed above. We will also explore the use of new technologies for drug discovery and therapy development in cancer and other complex disorders.

We welcome submissions from researchers, educators, and practitioners from around the world. 

Please visit our website for more information on submission guidelines and the peer-review process.

 

###

 

About JMIR Publications

JMIR Publications is a leading, born-digital, open access publisher of 30+ academic journals and other innovative scientific communication products that focus on the intersection of health, and technology. Its flagship journal, the Journal of Medical Internet Research, is the leading digital health journal globally in content breadth and visibility, and is the largest journal in the medical informatics field.

To learn more about JMIR Publications, please visit jmirpublications.com or connect with us via Twitter, LinkedIn, YouTube, Facebook, and Instagram.

Head office: 130 Queens Quay East, Unit 1100, Toronto, ON, M5A 0P6 Canada

Media contact: communications@jmir.org

The content of this communication is licensed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, published by JMIR Publications, is properly cited.

END


[Attachments] See images for this press release:
Call for papers: JMIR Bioinformatics and Biotechnology

ELSE PRESS RELEASES FROM THIS DATE:

SwRI’s Dr. Natalie Smith receives ASME Dedicated Service Award

SwRI’s Dr. Natalie Smith receives ASME Dedicated Service Award
2023-06-12
“It is an honor,” Smith said. “The ASME Turbo Expo community has been a valuable part of my professional development and it has been a pleasure to give back."  Since joining SwRI in 2016, Smith has performed aerodynamic design and testing of turbomachinery and advanced system analysis for programs related to power generation, aviation, oil and gas, and energy storage, including next-generation supercritical carbon dioxide power cycles. Smith has also managed three long-duration energy storage projects, developing a pumped thermal energy storage (PTES) demonstration facility, conducting a techno-economic feasibility study of ...

Press registration open for hybrid ACS Fall 2023 meeting

2023-06-12
Journalists who register for the fall meeting of the American Chemical Society (ACS) will have access to about 12,000 presentations on topics including agriculture and food, energy and fuels, health and medicine, sustainability and more. ACS Fall 2023 is a hybrid meeting being held virtually and in-person in San Francisco on Aug. 13-17 with the theme “Harnessing the Power of Data.” ACS considers requests for press credentials and complimentary registration to meetings from reporters (staff and freelance) and public information officers at government, nonprofit and ...

Loneliness, insomnia linked to work with AI systems

2023-06-12
Employees who frequently interact with artificial intelligence systems are more likely to experience loneliness that can lead to insomnia and increased after-work drinking, according to research published by the American Psychological Association. Researchers conducted four experiments in the U.S., Taiwan, Indonesia and Malaysia. Findings were consistent across cultures. The research was published online in the Journal of Applied Psychology. In a prior career, lead researcher Pok Man Tang, PhD, worked in an ...

FAU awarded $1.5 million teaching grant for adults with intellectual disabilities

FAU awarded $1.5 million teaching grant for adults with intellectual disabilities
2023-06-12
Florida Atlantic University’s College of Education has received a three-year $1.5 million grant through the Florida Center for Students with Unique Abilities (FCSUA) for the FAU Academy for Community Inclusion. The funds will help sustain the academy, an approved Florida Postsecondary Comprehensive Transition Program (FPCTP) that serves the community through continuing employment and independent living skills opportunities for adults with intellectual disabilities. Unemployment and under-employment for people with intellectual disabilities far exceed the norm – less than 10 percent of adults with intellectual ...

Many long COVID patients suffer from persistent inflammation, study finds

Many long COVID patients suffer from persistent inflammation, study finds
2023-06-12
An overactive inflammatory response could be at the root of many long COVID cases, according to a new study from the Allen Institute and Fred Hutchinson Cancer Center. Looking at proteins circulating in the blood, the scientists found a set of molecules associated with inflammation that were present only in a subset of patients with long COVID and were not seen in those who recovered from their disease. The researchers published an article describing their findings in the journal Nature Communications today. Out of 55 patients with long ...

All-electric rideshare fleet could reduce carbon emissions, increase traffic issues

2023-06-12
Two major ridesharing companies have promised all-electric fleets by 2030 in an effort to reduce their carbon footprint. To understand additional impacts of this transition, researchers reporting in ACS’ Environmental Science & Technology conducted life-cycle comparisons of battery-powered electric vehicle fleets to a gas-powered one, using real-world rideshare data. They found up to a 45% reduction in greenhouse gas emissions from full electrification; however, traffic problems and air pollution could increase. Ridesharing apps are an increasingly popular way to travel around urban areas, ...

Taking biofabrication to the next level: innovations in volumetric bioprinting

Taking biofabrication to the next level: innovations in volumetric bioprinting
2023-06-12
Taking biofabrication to the next level: innovations in volumetric bioprinting UMC Utrecht researchers propose solutions for bioprinting living tissue Bioprinting is the printing of living cells and tissues. It's a promising technique that hopefully, one day, can solve the organ donor shortage by growing organs from patients' own cells. However, printing living tissues and cells is extremely complicated, and many hurdles need to be overcome to be able to get there. In this article, three recent innovations ...

Insights into redox-independent cellular stress response

Insights into redox-independent cellular stress response
2023-06-12
Cellular stress, or oxidative stress, occurs when there is a buildup of reactive oxygen species (ROS), which interferes with cellular mechanisms and can even cause damage to proteins, lipids, and DNA. Owing to their destructive nature, all cells have robust mechanisms in place to remove ROS and reduce oxidative stress. One such mechanism is the nuclear factor erythroid 2-related factor 2 (NRF2)-mediated stress response, where NRF2 is a master transcription factor that aids in reducing oxidative stress.   Much is known about the redox-dependent activation of NRF2 and its subsequent role in stress response. In this pathway, ...

Chronic exposure to lead, cadmium and arsenic increases risk of cardiovascular disease

2023-06-12
Statement Highlights: Around the world, most people are regularly exposed to low or moderate levels of lead, cadmium and arsenic in the environment, increasing risk of coronary artery disease, stroke and peripheral artery disease, according to a new American Heart Association statement. These metals, considered contaminant metals, have no function in the human body. They are found in groundwater, water pipes, paint, tobacco products, fertilizer, plastic, electronics, gasoline, batteries, some foods and other commonly used items. Lead, ...

Which women should receive more than mammograms to screen for breast cancer?

2023-06-12
Study’s findings point to the importance of considering other risk factors beyond breast density. Dense breast tissue, which contains a higher proportion of fibrous tissue than fat, is a risk factor for breast cancer and also makes it more difficult to identify cancer on a mammogram. Many states have enacted laws that require women with dense breasts to be notified after a mammogram, so that they can choose to undergo supplemental ultrasound screening to improve cancer detection. A recent study published ...

LAST 30 PRESS RELEASES:

Science briefing: An update on GLP-1 drugs for obesity

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

[Press-News.org] Call for papers: JMIR Bioinformatics and Biotechnology
JMIR Bioinformatics and Biotechnology, published by JMIR Publications, welcomes submissions on all aspects of bioinformatics, computational biology, and biotechnology